The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 26, 2019
Filed:
Mar. 16, 2017
Applicant:
Virun, Inc., Pomona, CA (US);
Inventors:
Philip J. Bromley, Fullerton, CA (US);
Nurruzana Rahim, Walnut, CA (US);
Koon Zee Lam, Kuala Lumpur, MY;
Assignee:
Virun, Inc., Pomona, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 38/40 (2006.01); A61K 9/107 (2006.01); A61K 47/42 (2017.01); A61K 9/16 (2006.01); A61K 31/401 (2006.01); A61K 35/744 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 38/06 (2006.01); A61K 38/22 (2006.01); A61K 38/27 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/22 (2006.01); A61K 47/24 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 38/40 (2013.01); A61K 9/107 (2013.01); A61K 9/127 (2013.01); A61K 9/1617 (2013.01); A61K 9/1641 (2013.01); A61K 31/401 (2013.01); A61K 35/744 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 38/063 (2013.01); A61K 38/225 (2013.01); A61K 38/27 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61K 47/42 (2013.01); A61K 47/44 (2013.01);
Abstract
Compositions and methods for mucosal delivery of agents are provided. The compositions are intended for administration to mucosal surface, such as oral, gastrointestinal and nasal mucosa. The compositions provided contain one or more mucoadhesive proteins and an agent to be delivered. Methods for delivery of agents using the compositions provided herein are also provided.